Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

Sen, Jon, Belli, Antonio, Albon, Helen, Morgan, Laleh, Petzold, Axel and Kitchen, Neil (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage Lancet Neurology, 2, (10), pp. 614-620. (doi:10.1016/S1474-4422(03)00531-3).


Full text not available from this repository.


Cerebral vasospasm is a recognised but poorly understood complication for many patients who have aneurysmal subarachnoid haemorrhage and can lead to delayed ischaemic neurological deficit (stroke). Morbidity and mortality rates for vasospasm are high despite improvements in management. Since the middle of the 1970s, much has been written about the treatment of cerebral vasospasm. Hypervolaemia, hypertension, and haemodilution (triple-H) therapy in an intensive-care setting has been shown in some studies to improve outcome and is an accepted means of treatment, although a randomised controlled trial has never been undertaken. In this review, the rationale for this approach will be discussed, alongside new thoughts and future prospects for the management of this complex disorder.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1016/S1474-4422(03)00531-3
ISSNs: 1474-4422 (print)
Related URLs:
ePrint ID: 27710
Date :
Date Event
October 2003Published
Date Deposited: 25 Apr 2006
Last Modified: 16 Apr 2017 22:29
Further Information:Google Scholar

Actions (login required)

View Item View Item